A Systems Approach to Improve Safe Medication Management for Children with Medical Complexity
Project Number5K01MD016167-04
Former Number1K01MD016167-01A1
Contact PI/Project LeaderABEBE, EPHREM
Awardee OrganizationPURDUE UNIVERSITY
Description
Abstract Text
PROJECT SUMMARY
The proposed research addresses a key patient safety gap among children with medical complexity (CMC)
transitioning between hospital and home—medication related harm. CMC are often on multiple and complex
medication regimens and have intensive healthcare needs. As a result, they experience frequent transitions of
care, across professional roles and care settings and during these transitions, CMC are at great risk for
medication-related harm. Most transitional care interventions have been adopted from adult care settings and
may not be adequate to address the unique needs of CMC and their family caregivers. Interventions that are
grounded in the unique situations and complexities of such patients are needed to improve medication use
safety and family experience of care.
This proposal describes the PI’s plan to transition into an independent investigator by developing expertise in
1) participatory, human centered design to co-develop useful interventions, and 2) implementing and
evaluating interventions. The proposal also describes a 4-year project for developing a prototype care
transition medication safety intervention and generating early evidence on its usability and potential factors
influencing its future implementation.
Aim 1: Patient journey mapping—will be used to elucidate medication safety risks and contexts during the
hospital-to-home transition period. Journey maps will be used to capture and visually represent the medication
use experience of families across professional settings and boundaries. The output of this aim will inform
prototype design under Aim 2.
Aim 2: Participatory, human centered design to co-design a prototype medication safety intervention. Through
multiple, iterative co-design sessions involving healthcare workers and family caregivers, a team will design a
prototype medication safety intervention informed by journey maps from Aim 1, current literature, and
participant elicitations. The result will be a composite prototype ready for usability testing.
Aim 3: Will test usability of prototype intervention with healthcare workers and family caregivers. Additionally,
barriers and facilitators that may be anticipated during future prototype implementation will be explored. Taken
together, all 3 aims will yield a final, refined prototype intervention designed to improve medication use safety
during care transitions.
Future work will include a randomized controlled trial of the prototype medication safety intervention to
formally evaluate it effectiveness in preventing or reducing medication related harm as well as improving the
medication use experience of CMC and their family caregivers.
Public Health Relevance Statement
PROJECT NARRATIVE
Children with medical complexity (CMC) have a high risk of experiencing medication related harm but can
benefit from interventions that involve their caregivers as co-designers. This award will support the candidate’s
(1) training in participatory, human centered design and (2) skill development in implementation and evaluation
research to design and test interventions fit for unique needs of CMC.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AcademyAddressAdmission activityAdoptedAdultAmericanAwardBehavior TherapyBehavioral ModelCaregiversCaringChildComplexConsolidated Framework for Implementation ResearchContinuity of Patient CareDataDischarge PlanningsEffectivenessEngineeringEnsureEvaluation ResearchFailureFamilyFamily CaregiverFutureGoalsHealth CareHealth Care SystemsHealth PersonnelHomeHospitalsHumanIndividualInpatientsInterventionInterviewJointsKnowledgeLawsLiteratureMapsMeasuresMedicaidMedicalMedication ManagementModelingOutputParticipantPatient Self-ReportPatientsPediatricsPerformancePersonsPharmaceutical PreparationsPhaseProfessional RoleRandomized, Controlled TrialsRecommendationRegimenReportingResearchResearch PersonnelResourcesRiskRoleSafetyScheduleSolidSpecific qualifier valueStatutes and LawsSystemTechnologyTestingTrainingUnited States National Institutes of HealthVisualWorkcare coordinationcareer developmentchild health carecostdesigneffectiveness/implementation hybridevidence baseexperiencefuture implementationhigh riskhuman centered designimplementation researchimprovedmedication safetypatient orientedpatient populationpatient safetypediatric patientspreventprototypeskill acquisitionsuccesssuccessful interventiontext searchingtherapy designtherapy developmenttoolusability
National Institute on Minority Health and Health Disparities
CFDA Code
307
DUNS Number
072051394
UEI
YRXVL4JYCEF5
Project Start Date
13-May-2022
Project End Date
31-January-2026
Budget Start Date
01-February-2025
Budget End Date
31-January-2026
Project Funding Information for 2025
Total Funding
$113,518
Direct Costs
$105,109
Indirect Costs
$8,409
Year
Funding IC
FY Total Cost by IC
2025
National Institute on Minority Health and Health Disparities
$113,518
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5K01MD016167-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K01MD016167-04
Patents
No Patents information available for 5K01MD016167-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K01MD016167-04
Clinical Studies
No Clinical Studies information available for 5K01MD016167-04
News and More
Related News Releases
No news release information available for 5K01MD016167-04
History
No Historical information available for 5K01MD016167-04
Similar Projects
No Similar Projects information available for 5K01MD016167-04